Logo

Senores Pharmaceutic Share Price

Senores Pharmaceutic (INR)502.85-28.4   (-5.3%)

Exchange ScripsBSE544319NSESENORESISININE0RB801010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Senores Pharmaceutic Performance

Market performance
Open price540
High541.95
Volumes684025
Prev Close502.85
Low500.25
Closing date2025-01-10
Historical performance
1 Year High609.65
3 Year High609.65
5 Year High609.65
1 Year Low500.25
3 Year Low500.25
5 Year Low500.25

Senores Pharmaceutic Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
2316
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
48.77
Dividend Yield
Dividend Yield
N/A

Senores Pharmaceutic Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Senores Pharmaceutic Technicals

IndicatorsValueSignal
5-DMA540.52Bearish
10-DMA554.56Bearish
20-DMA
50-DMA
100-DMA
200-DMA

Shareholding Pattern

FieldSep-2024
Promoters16
Foreign Investors3
Domestic Investors13
Public Investors43691
Government---

Senores Pharmaceutic Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Other Income28375
Operating Profit44416424
Interest94216
Depreciation100187
Profit Before Tax24912411
Consolidated Net Profit3158410
Adjusted EPS1091

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Share Capital3059887
Total Reserves1738357278
Minority Interest274------
Total Non-Current Liabilities1277337122
Total Liabilities60691311587
Capital Work in Progress178813
Total Assets60691311587

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022
Cash Flow from Operating Activities-199-11-104
Cash Flow from Investing Activities-547-483-244
Cash Flow from Financing Activitie870463365
Net Cash Inflow / Outflow125-3116
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 48.77.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 1.7.
  • In the last financial year, the company had an EBITDA of ₹444 Million.
  • The company generated revenue of ₹2145 Million in the previous financial year.

Senores Pharmaceutic

502.85-28.4   (-5.3%)

Investment Amount: ₹ 55705
Current Value: ₹ 50285
Performance: -9.7%
P/L: ₹ -5420
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month